台灣創投 · 2026 年 10 月第 2 週

生技產值8,301億元,醫療新創募資件數與金額卻雙降

經濟日報 · 2026-10-07

勤業眾信陳重成指出,2025年台灣生技產業營收8,301億元、年增7.05%,但健康醫療新創募資126件、6.6億美元,件數與金額分別減11%、16%。獲投新創年齡中位數升至5至6年,資金被AI與半導體吸走,新創須提早規劃商業化。

Biotech revenue hits NT$830.1 billion, but health startup deals and funding both fall

Deloitte Taiwan's Chen Chung-cheng said Taiwan's biotech revenue reached NT$830.1 billion in 2025, up 7.05%, yet health startups closed 126 deals worth US$660 million, down 11% in count and 16% in value. The median age of funded firms rose to 5–6 years as AI and chips draw capital away, so startups must plan commercialization earlier.

閱讀原文 ↗

← 回到本週觀察